Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 24;6(1):e000429.
doi: 10.1136/bmjresp-2019-000429. eCollection 2019.

Prevalence and outcome of central airway obstruction in patients with lung cancer

Cyrus Daneshvar  1 , William Euan Falconer  1 , Mohammed Ahmed  2 , Abdul Sibly  1 , Madeleine Hindle  1 , Thomas W Nicholson  1 , Ghanem Aldik  1 , Lilanganee A Telisinghe  3 , Richard D Riordan  4 , Adrian Marchbank  5 , David Breen  6
Affiliations

Prevalence and outcome of central airway obstruction in patients with lung cancer

Cyrus Daneshvar et al. BMJ Open Respir Res. .

Abstract

Introduction: Central airway obstruction (CAO) is a life-threatening complication of lung cancer. The prevalence of CAO in lung cancer patients is unknown. We audited CAO burden to inform our local cancer service.

Methods: This is a cohort review of all new lung cancer diagnoses between 1 November 2014 and 30 November 2015. CAO was defined by CT appearance. CT scans and routine patient records were followed up to 30 November 2018 to determine the prevalence of CAO at diagnosis; the characteristics of patients with prevalent CAO; mortality (using survival analysis); and incident CAO over follow-up.

Results: Of 342 new lung cancer diagnoses, CAO prevalence was 13% (95% CI 10% to 17%; n=45/342). Dedicated CT scan review identified missed CAO in 14/45 (31%) cases. In patients with prevalent CAO, 27/44 (61%) had a performance status of ≤2, 23/45 (51%) were diagnosed during an acute admission and 36/44 (82%) reported symptoms. Treatments were offered to 32/45 (71%); therapeutic bronchoscopy was performed in only 8/31 (26%) eligible patients. Median survival of patients with prevalent CAO was 94 (IQR 33-274) days. Multivariate analysis, adjusting for age, gender and disease stage, found CAO on index CT scan was independently associated with an increased hazard of death (adjusted HR 1.78 (95% CI 1.27 to 2.48); p=0.001). In total, 15/297 (5%) developed CAO during follow-up (median onset 340 (IQR 114-551) days). Over the audit period, 60/342 (18%; 95% CI 14% to 22%) had or developed CAO.

Discussions: This is the first description of CAO prevalence in 40 years. Patients with prevalent CAO had a higher mortality. Our data provide a benchmark for service planning.

Keywords: bronchoscopy; clinical epidemiology; imaging/CT MRI etc; lung cancer; non-small cell lung cancer; palliative care; small cell lung cancer; thoracic surgery.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Patient cohort flow chart. CAO, central airway obstruction.
Figure 2
Figure 2
Treatment modalities in patients with central airway obstruction.
Figure 3
Figure 3
Kaplan-Meier survival curve for patients with and without central airway obstruction (CAO).
See this image and copyright information in PMC

References

    1. NLCA National lung cancer audit annual report 2016. 2017.
    1. Ernst A, Feller-Kopman D, Becker HD, et al. . Central airway obstruction. Am J Respir Crit Care Med 2004;169:1278–97. 10.1164/rccm.200210-1181SO - DOI - PubMed
    1. Brewer LA, Bai AF, Little JN, et al. . Carcinoma of the lung; practical classification for early diagnosis and surgical treatment. J Am Med Assoc 1958;166:1149–55. - PubMed
    1. Brewer LA. Patterns of survival in lung cancer. Chest 1977;71:644–50. 10.1378/chest.71.5.644 - DOI - PubMed
    1. Abdel-Rahman O. Changing epidemiology of elderly small cell lung cancer patients over the last 40 years; a seer database analysis. Clin Respir J 2017. - PubMed

Publication types